IRadimed Q1 Earnings Snapshot

IRMD Stock  USD 53.58  0.83  1.57%   
About 55% of Iradimed's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Iradimed Co stock suggests that some investors are interested at this time. The current market sentiment, together with Iradimed's historical and current headlines, can help investors time the market. In addition, many technical investors use Iradimed stock news signals to limit their universe of possible portfolio assets.
  
IRMD on Thursday reported net income of 4.1 million in its first quarter. On a per-share basis, the Winter Springs, Florida-based company said it had net income of 32 cents. Earnings, adjusted for stock option expense, came to 36 cents per share.

Read at finance.yahoo.com
Yahoo News
  

Iradimed Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Iradimed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Iradimed Fundamental Analysis

We analyze Iradimed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iradimed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iradimed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Iradimed is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Iradimed Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iradimed stock to make a market-neutral strategy. Peer analysis of Iradimed could also be used in its relative valuation, which is a method of valuing Iradimed by comparing valuation metrics with similar companies.

Peers

Iradimed Related Equities

LIVNLivaNova PLC   3.53   
0%
100.0%
ANIKAnika Therapeutics   3.02   
0%
85.0%
ELMDElectromed   1.87   
0%
52.0%
ITGRInteger Holdings   1.46   
0%
41.0%
GKOSGlaukos Corp   1.39   
0%
39.0%
NPCENeuropace   0.49   
0%
13.0%
SRDXSurModics   0.10   
2.0%
0%
CNMDCONMED   0.99   
28.0%
0%
OFIXOrthofix Medical   1.09   
30.0%
0%
SGHTSight Sciences   1.76   
49.0%
0%
KIDSOrthopediatrics Corp   2.01   
56.0%
0%
LUNGPulmonx Corp   2.48   
70.0%
0%

Complementary Tools for Iradimed Stock analysis

When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance